Rifagi 550 Tablet
Marketer
Manith Healthcare Pvt Ltd
Salt Composition
Rifaximin (550mg)
Overview Rifagi 550 Tablet
Hepatic encephalopathy, a liver-related condition causing toxin buildup and brain damage, is treated with Rifagi 550mg tablets, an antibiotic. This medication also combats infectious diarrhea. Its mechanism involves eliminating and inhibiting intestinal bacteria growth. Rifagi 550 may be administered independently or alongside other drugs, with or without food, consistently at the same time daily. Dosage and treatment length should follow your physician's instructions; consistent daily intake maximizes effectiveness. Premature discontinuation risks infection recurrence and treatment complications. Potential side effects, including nausea, vomiting, headaches, dizziness, skin rashes, arthralgia, and depression, are typically transient, resolving as the body adapts. Persistent or bothersome side effects warrant medical consultation. Note that this medication can cause harmless reddish urine. Prior to commencing treatment, disclose any pregnancy, breastfeeding, liver, kidney, or heart issues, or medication allergies to your doctor.
Primary Ingredients of Rifagi 550 Tablet
No text provided to rephrase.
Uses of Rifagi 550 Tablet
Managing hepatic encephalopathy and infectious diarrhea.
Major Benefits of Rifagi 550 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rifagi 550 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Rifagi 550 Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Ascites (accumulation of fluid in the abdominal cavity)
- Fatigue
- Depression
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Joint pain
- Rash
- Muscle pain
How to use Rifagi 550 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or break it. Rifagi 550 Tablets can be consumed with or without food, however, consistent timing is recommended.
How Rifagi 550 Tablet works:
Rifagi 550mg tablets are an antibacterial medication. Their mechanism of action involves eliminating ammonia-generating bacteria within the gastrointestinal system. This addresses the underlying infection and alleviates hepatic encephalopathy symptoms such as restlessness, cognitive impairment, and neuromuscular dysfunction. Furthermore, this treatment helps prevent future hepatic encephalopathy episodes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rifagi 550 Tablet may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Rifagi 550 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available data, Rifagi 550 Tablet appears to pose minimal risk during lactation. Studies in humans indicate insignificant harm to the infant.
DrivingSAFE
Driving ability is typically unaffected by Rifagi 550 Tablet.
KidneySAFE IF PRESCRIBED
The use of Rifagi 550 Tablet in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Rifagi 550 Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Rifagi 550 Tablet :
Should you forget a Rifagi 550 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Rifagi 550 Tablet
| Label | Value |
|---|---|
| Chemical Category | Rifamycin-based compounds |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Action Category | Rifamycin Antibiotics: RNA Polymerase Inhibitors |



